maybe some stuff was shared like clinical development pipeline - they had insight into plans for this new drug?
do you think the sophisticated investors and funds would have jumped on board in October with insight into the share price in 6 months? Maybe they thought, it’s 50% down from highs, expecting accelerated approval, this is a great investment.
or, maybe they were told exactly the timelines as they have panned out and are happy to hold for a couple extra years for decent traction.
we’ll never know, I’m sharing my opinions - but what is a fact is 12 months ago the company communicated an NDA would be planned to be submitted Q1 this year. Now I’m assuming it’s 12-18 months away based on this update.
LTP Price at posting:
43.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)